Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8;13(1):62.
doi: 10.3390/antibiotics13010062.

High Prevalence of Multidrug-Resistant Bacteria in the Trachea of Intensive Care Units Admitted Patients: Evidence from a Bangladeshi Hospital

Affiliations

High Prevalence of Multidrug-Resistant Bacteria in the Trachea of Intensive Care Units Admitted Patients: Evidence from a Bangladeshi Hospital

Sabrina Haque et al. Antibiotics (Basel). .

Abstract

Recent research has shown that antibiotic-resistant microorganisms are becoming more prevalent in intensive care units (ICUs) at an exponential rate. Patients in the ICU can get infected by pathogens due to invasive operation procedures and critical health conditions. This study primarily emphasized tracheal samples from ICU patients due to their reliance on ventilators, increasing their susceptibility to Ventilator-Associated Pneumonia (VAP). Moreover, the rise of multidrug-resistant (MDR) pathogens makes treatment strategies more challenging for these patients. In this study, we tested 200 tracheal specimens to determine the prevalence of microorganisms and analyzed the antibiotic susceptibility of these isolates against regular antibiotics, including 4th generation drugs. Among the 273 isolates, 81% were gram-negative bacteria, 10% were gram-positive bacteria, and 9% were fungi. The most prevalent gram-negative bacteria were Acinetobacter spp. (34%), Klebsiella spp. (22%), Pseudomonas spp. (14%), and Escherichia coli (9.2%). The most prevalent gram-positive bacteria were Staphylococcus aureus (5.9%), and the fungi were Candida spp. (7.3%). Among the most prevalent bacteria, except Staphylococcus aureus isolates, around 90% were resistant to multiple drugs, whereas 60% of Acinetobacter spp. and Pseudomonas spp. were extensively drug resistant. Sensitivity analysis against the gram-negative and gram-positive drug panel using a one-way ANOVA test followed by Tukey's post hoc test showed that in the in vitro assay, colistin was the most effective antibiotic against all gram-negative bacteria. In contrast, linezolid, vancomycin, and fusidic acid were most effective against all gram-positive bacteria. Regular monitoring of nosocomial infections and safe management of highly resistant bacteria can help prevent future pandemics.

Keywords: ICU patient; effective antibiotic; multidrug-resistant bacteria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of microorganisms. The figure specifies in percentages whether the infection was monobacterial or polybacterial. It also includes the cases with fungal infection.
Figure 2
Figure 2
Most effective drugs against gram-negative bacteria according to Tukey’s post hoc comparison.

Similar articles

Cited by

References

    1. Zilahi G., Artigas A., Martin-Loeches I. What’s new in multidrug-resistant pathogens in the ICU? Ann. Intensive Care. 2016;6:96. doi: 10.1186/s13613-016-0199-4. - DOI - PMC - PubMed
    1. Heddini A., Cars O., Qiang S., Tomson G. Antibiotic resistance in China—A major future challenge. Lancet. 2009;373:30. doi: 10.1016/S0140-6736(08)61956-X. - DOI - PubMed
    1. Bonten M.J.M., Mascini E.M. The hidden faces of the epidemiology of antibiotic resistance. Intensive Care Med. 2003;29:1–2. doi: 10.1007/s00134-002-1564-3. - DOI - PubMed
    1. Lo Yan Yam E., Hsu L.Y., Yap E.P.H., Yeo T.W., Lee V., Schlundt J., Lwin M.O., Limmathurotsakul D., Jit M., Dedon P.C., et al. Antimicrobial Resistance in the Asia Pacific region: A meeting report. Antimicrob. Resist. Infect. Control. 2019;8:202. doi: 10.1186/s13756-019-0654-8. - DOI - PMC - PubMed
    1. World Health Organization . Antimicrobial Resistance: Global Report on Surveillance. World Health Organization; Geneva, Switzerland: 2014.

LinkOut - more resources